Artículos de revistas
COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE VERSUS WARFARIN FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION UNDER THE PRIVATE AND PUBLIC HEALTH CARE SYSTEM IN BRAZIL
Registro en:
Value In Health. Elsevier, v.15, n.4, p.A122-A122, JUN, 2012
1098-3015
WOS:000304468200630
Autor
Nasciben, V
Figueiredo, M. J. D. O.
Darrieux, F. C. D. C.
Piegas, L. S. P.
Martins, S. C. O.
Institución
Resumen
15 4 A122 A122